FR2682967B1 - Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques. - Google Patents

Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.

Info

Publication number
FR2682967B1
FR2682967B1 FR9113227A FR9113227A FR2682967B1 FR 2682967 B1 FR2682967 B1 FR 2682967B1 FR 9113227 A FR9113227 A FR 9113227A FR 9113227 A FR9113227 A FR 9113227A FR 2682967 B1 FR2682967 B1 FR 2682967B1
Authority
FR
France
Prior art keywords
paratuberculosis
cloning
expression
nucleotide sequences
new promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9113227A
Other languages
English (en)
Other versions
FR2682967A1 (fr
Inventor
Alan Murray
Marina Gheorghiu
Brigitte Gicquel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Massey University
Original Assignee
Institut Pasteur
Massey University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur, Massey University filed Critical Institut Pasteur
Priority to FR9113227A priority Critical patent/FR2682967B1/fr
Priority to EP92922721A priority patent/EP0666917A1/fr
Priority to US08/211,718 priority patent/US5968815A/en
Priority to PCT/EP1992/002431 priority patent/WO1993008284A1/fr
Priority to JP5507458A priority patent/JPH07504082A/ja
Priority to NZ244901A priority patent/NZ244901A/en
Publication of FR2682967A1 publication Critical patent/FR2682967A1/fr
Application granted granted Critical
Publication of FR2682967B1 publication Critical patent/FR2682967B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9113227A 1991-10-25 1991-10-25 Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques. Expired - Fee Related FR2682967B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9113227A FR2682967B1 (fr) 1991-10-25 1991-10-25 Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
EP92922721A EP0666917A1 (fr) 1991-10-25 1992-10-23 Promoteur de m. paratuberculosis et son utilisation pour l'expression de sequences immunogenes
US08/211,718 US5968815A (en) 1991-10-25 1992-10-23 Promoter of M. paratuberculosis and its use for the expression of immunogenic sequences
PCT/EP1992/002431 WO1993008284A1 (fr) 1991-10-25 1992-10-23 Promoteur de m. paratuberculosis et son utilisation pour l'expression de sequences immunogenes
JP5507458A JPH07504082A (ja) 1991-10-25 1992-10-23 Ｍ．Ｐａｒａｔｕｂｅｒｃｕｌｏｓｉｓのプロモーター及び免疫原性配列の発現のためのその使用
NZ244901A NZ244901A (en) 1991-10-25 1992-10-27 Mycobacterium paratuberculosis nucleotide sequence and its use in vectors and host cells for cloning and expression of nucleotide sequences; vaccines containing the host cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113227A FR2682967B1 (fr) 1991-10-25 1991-10-25 Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.

Publications (2)

Publication Number Publication Date
FR2682967A1 FR2682967A1 (fr) 1993-04-30
FR2682967B1 true FR2682967B1 (fr) 1994-01-14

Family

ID=9418341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9113227A Expired - Fee Related FR2682967B1 (fr) 1991-10-25 1991-10-25 Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.

Country Status (6)

Country Link
US (1) US5968815A (fr)
EP (1) EP0666917A1 (fr)
JP (1) JPH07504082A (fr)
FR (1) FR2682967B1 (fr)
NZ (1) NZ244901A (fr)
WO (1) WO1993008284A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313719T3 (es) 1993-11-23 2009-03-01 The Regents Of The University Of California Productos extracelulares abundantes y procedimiento de produccion y uso de los mismos.
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
WO1996008579A1 (fr) * 1994-09-16 1996-03-21 Alan Murray Procedes de detection de mycobacteries pathogenes
GB9526178D0 (en) 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
GB9806093D0 (en) * 1998-03-20 1998-05-20 Taylor John Hermon Diagnostics and vaccines for mycobacterial infections of animals and humans
US7074559B2 (en) * 2002-03-06 2006-07-11 Refents of the University of Minnesota Mycobacterial diagnostics
NZ519469A (en) * 2002-06-10 2005-01-28 Agres Ltd Nucleic acid probes for detecting the presence of Mycobacterium paratuberculosis and distinguishing between cattle and sheep strains
ATE466876T1 (de) 2005-08-09 2010-05-15 Hav Vaccines Ltd Immunogene konstrukte
EP2025762A3 (fr) 2006-01-17 2009-09-30 Health Research Inc. Analyse de suivi hétéroduplex
US7999153B2 (en) * 2008-08-08 2011-08-16 Monsanto Technology Llc Soybean variety D5502014

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
EP0400973B1 (fr) * 1989-05-31 1996-07-31 Ajinomoto Co., Inc. Vecteurs d'expression et de sécrétion pour mycobacterium et les transformants
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria

Also Published As

Publication number Publication date
FR2682967A1 (fr) 1993-04-30
US5968815A (en) 1999-10-19
JPH07504082A (ja) 1995-05-11
NZ244901A (en) 1995-07-26
WO1993008284A1 (fr) 1993-04-29
EP0666917A1 (fr) 1995-08-16

Similar Documents

Publication Publication Date Title
EP0575123A3 (fr) Composition d'un copolymère d'éthylène.
GR3035574T3 (en) Use of substituted benzimidazoles.
GR3032608T3 (en) Cloning and expression of renilla luciferase.
EP0623359A3 (fr) Manchon de sûreté pour aiguilles.
ATE74804T1 (de) Verringerung des durchmessers von rohrfoermigen koerpern.
FR2672781B3 (fr) Coulant pour parapluie et articles similaires.
FI881881L (fi) Hylsa foer uppbaerande av en tandprotes.
DE69204290D1 (de) Verwendung von 1,2,2,3,3-pentafluorpropan.
DE68908299D1 (de) Verschleissfeste metallurgische duese.
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
FI935317L (fi) Krossverk, saerskilt slag krossverk
FI884152A0 (fi) Golvbelaeggning av elektriskt ledande slag.
ITRM920440A1 (it) Agenti ausiliari per operazioni di tintura e loro impiego.
DE59204051D1 (de) Verwendung von polymodalem beta-Oktogen.
FR2677996B1 (fr) Vecteurs de clonage et/ou d'expression preparation et utilisation.
FR2699716B1 (fr) Manchon d'étiquetage.
ITTO930806A0 (it) Purificazione dell' 1,1-dicloro-1-fluoroetano.
DE69423361D1 (de) Geklonte pullulanase
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
FR2707892B3 (fr) Catalyseur de déshydrogénation et son utilisation pour la déshydrogénation d'éthylbenzène.
DE59202897D1 (de) Kohlenstoffkörper mit Siliziumkarbid-Beschichtung und Verfahren zu ihrer Herstellung.
FR2693475B1 (fr) Procédé d'identification et/ou de clonage de promoteurs transcriptionnels, et utilisation de ces promoteurs pour l'expression de gènes.
FI883051L (fi) Metallurgisk dysa.
EP0618298A3 (fr) Promoteur bidirectionelle des gènes pcbAB et pcbC d'acremonium chrysogenum et son utilisation.
Kurelek " When are you leaving?" search for an appropriate research methodology for work with aboriginal peoples.

Legal Events

Date Code Title Description
ST Notification of lapse